All posts by medical

Active Ingredients in Sunscreen Detrimental to Freshwater Ecosystems – Technology Networks

The active ingredients found in sunscreen have detrimental effects on freshwater ecosystems, according to new research by University of Alberta biologists.

The results show that long-term exposure to ultraviolet (UV) filtersincluding avobenzone, oxybenzone, and octocryleneis lethal for some organisms living in freshwater environments. One of the largest sources of UV-filter contamination in both marine and freshwater environments is from sunscreen leaching off of the skin while swimming.

We do know that UV-filters are particularly devastating to coral reefs and cause bleaching, but there has been almost no research on what the effects are to freshwater animals, explained Aaron Boyd, graduate student in the Department of Biological Sciences and lead author on the paper. To address this, we examined the effects of UV-filters in the water flea, Daphnia magna.

The results show that exposure to UV-filters over a 48-hour period prevented the fleas from navigating through their environment. Exposure over a 14-day periodsimilar to what might occur near popular beach areasproved lethal for the tiny crustaceans.

This is particularly bad for a freshwater ecosystem as a whole, as Daphnia are an important part of the food chain for many smaller species of fish, added Boyd, who completed this research in collaboration with graduate student Connor Stewart, under the supervision of Assistant Professor Tamzin Blewett and Professor Keith Tierney. Losing a Daphnia population would put all of the species that rely on them at risk of starvation, and in certain conditions could cause the local ecosystem to collapse.

The good news, Boyd explained, is that the fleas were able to recover their ability to navigate through the water once the contamination was removeda good sign for environmental recovery. These chemicals are short-lived in the environment, so if we remove the sources of pollution, then there is a reasonable chance for the organisms in those environments to recover, he said.

Further research is required to better understand the long-term impact of UV-filtersand research continues in the search for non-toxic UV filters.

ReferenceBoyd A, Stewart CB, Philibert DA, et al. A burning issue: The effect of organic ultraviolet filter exposure on the behaviour and physiology of Daphnia magna. Science of The Total Environment. 2021;750:141707. doi:10.1016/j.scitotenv.2020.141707

This article has been republished from the following materials. Note: material may have been edited for length and content. For further information, please contact the cited source.

Read the original post:
Active Ingredients in Sunscreen Detrimental to Freshwater Ecosystems - Technology Networks

Diagnostic Errors in the COVID-19 Era – Medscape

Editor's note: Some details have been changed to protect the patient's identity.

Jaya Mallidi, MD, MHS

It was an unusually quiet Saturday afternoon on call. I was sipping coffee and leisurely reading that day's echocardiograms. On one, ordered for an indication of "dyspnea," there was a moderate-sized pericardial effusion without tamponade physiology. I called the ordering hospitalist to tell him the results.

He mentioned that the patient was admitted the previous day as a "COVID rule-out." Mr Gonzales was a 55-year-old man with progressively worsening exertional shortness of breath and cough over the previous 2 weeks. A chest x-ray showed cardiomegaly, concerning for pericardial effusion. His vital signs were stable and he was admitted with a diagnosis of viral pericarditis and high suspicion for COVID-19. Rapid SARS-CoV-2 testing was negative, but another test was ordered given the high clinical suspicion.

I called the lab for the second COVID-19 test result but was told that it would not be available for several hours. With not much clinical activity going on, I decided to go see Mr Gonzales. I donned the necessary personal protective equipment and entered his room.

Mr Gonzales was propped up in the bed. A yellow mask covered his mouth but stopped short of covering his nostrils. His eyes looked tired, like those of a man who had not slept in days. I introduced myself and asked how he was doing. After a long pause, he shook his head and mumbled, "Not good." His voice was unusually hoarse. He could not lie flat comfortably. He could not walk 10 yards without dyspnea. I wondered whether the effusion needed to be tapped. Unusual to have this degree of symptoms without any tamponade physiology.

As I stood at his bedside, unsure of what to do, he raised his hands to the sides of his neck. "It's swollen, my neck," he said. That's when I noticed that his neck was somewhat thick, more than what one would expect for his sturdy build. The supraclavicular fossa (the indentation above the clavicular bone) was obliterated and full. On palpation, I felt the hard, irregular surface of the supraclavicular lymph nodes. Check for malignancy, I thought. I informed him that we would need to do a CT scan of his neck and chest to find out what is going on.

Diagnostic errors, either missed, inaccurate, or delayed, were a common source of potential patient harm even before this pandemic. The Institute of Medicine, in its report "Improving Diagnosis in Health Care," defined diagnostic error as the failure to establish an accurate and timely explanation of the patient's health problem or communicate that problem to the patient.

Cognitive shortcuts to aid in decision-making are important sources of diagnostic error in medicine. Traditionally the diagnostic process is iterative. Accuracy and timeliness are subjective and largely depend on the patient's clinical presentation. In the COVID-19 era, an accurate diagnosis is focused on ruling the disease in or out, and the rest of the diagnostic workup begins only after this. While these new processes are important from a public health standpoint, for an individual patient, especially one presenting with a non-COVID-19 illness, the virus has become a hurdle in the diagnostic process, already strained by cognitive biases and system-based errors (Figure).

Adapted from Improving Diagnosis in Health Care .

A recent perspective by two patient quality and safety experts, Tejal Gandhi and Hardeep Singh, describes several types of anticipated diagnostic errors in the COVID-19 era. With universal availability of testing, missing COVID-19 in a patient presenting to the ED is unlikely. The more relevant error at this phase of the pandemic is a delayed or missed non-COVID diagnosis. The following common clinical fallacies can lead to diagnostic errors, especially now.

Anchoring bias. This cognitive bias occurs when the decision-making is predominantly based on the initial information provided. With Mr Gonzales, the initial framing was toward COVID-19. It was such a strong anchor that even rapid negative testing did not result in a reevaluation of the diagnosis. In the past few months, I have personally witnessed and read case reports of common disorders such as acute myocardial infarction being missed because of anchoring to a COVID-19 diagnosis.

Availability bias. With the raging pandemic, we physicians have COVID-19 on our minds. All patients presenting with respiratory complaints are assumed to have COVID-19 unless proven otherwise, because this is the most readily available explanation.

Base rate neglect. The prevalence of SARS-CoV-2 has significant geographical variation. In an area with low prevalence, a patient who presents with respiratory symptoms has a higher probability of a non-COVID condition, such as pulmonary edema from myocardial infarction, bacterial pneumonia, bronchitis, COPD, or heart failure. However, the underlying population-based prevalence is often ignored in everyday clinical medicine.

The tainted practice of modern medicine, where physicians review the EHR before meeting patients, as well as the note bloat from copy-paste problem lists, is a perfect set-up for diagnostic errors. To avoid errors and overcome our cognitive biases, we need to spend adequate time with patients, carefully integrating history, examination, and test results. In the fast-paced, chaotic world of modern medicine, where compensation rewards volume and not cognitive thinking, this needed time is missing.

Instead, we have burnout associated with the pressure to see more patients and generate more wRVUs. During a pandemic, there are new care processes, specific to each hospital, to rule out/rule in COVID-19, not to mention the rational fear for our own safety and the mental fatigue associated with that.

The risk for diagnostic errors is enhanced in this kind of environment. It can be difficult to measure this kind of error, and to date, we do not have objective data to definitively prove that there are more diagnostic errors in the COVID-19 era. I suspect, however, that the rate of diagnostic errors is higher than in pre-pandemic times. It's important for physicians to be extra vigilant during this period.

The CT scan of Mr Gonzales' chest and neck showed a mass in his lung that extended to the mediastinal structures causing significant laryngeal edema (and his hoarse voice) and superior vena cava syndrome. An urgent biopsy found stage IV adenocarcinoma of the lung. Given the patient's significant respiratory symptoms, the oncologist initiated in-patient radiation treatment in addition to intravenous steroids. Later, Mr Gonzales asked me why no one did the CT scan earlier despite him complaining about his swollen neck. Cognitive bias; a near miss, I thought. "We had to make sure COVID was ruled out," I answered.

Jaya Mallidi is an interventional cardiologist in Santa Rosa, California. An ardent patient advocate, she writes opinion pieces using patient stories as context to highlight problems in the practice of modern-day medicine. In addition, she enjoys digital sketching and playing tennis.

Follow Jaya Mallidi on Twitter

Follow theheart.org | Medscape Cardiology on Twitter

Follow Medscape on Facebook, Twitter, Instagram, and YouTube

Read the original post:
Diagnostic Errors in the COVID-19 Era - Medscape

Peloton Introduces Its First-Ever Health And Wellness Advisory Council – PRNewswire

NEW YORK, Sept. 1, 2020 /PRNewswire/ -- Peloton (NASDAQ: PTON), the world's largest interactive fitness platform, today announced the formation of the Peloton Health and Wellness Advisory Council, which will work closely with the company as it continues to look at how it can positively impact the physical, mental and emotional wellbeing of its community of Members from around the world. Peloton will collaborate with the council, which includes five renowned doctors, researchers and other medical professionals from the fields of cardiovascular medicine, cardiopulmonary exercise, neurology and neuroscience, and draw on their knowledge and expertise to help inform product and content development, community-focused and social impact initiatives, research projects and more.

"We constantly hear from our Members that Peloton has not only profoundly impacted their physical, mental and emotional health, but has also helped them cope with issues ranging from neurodegenerative disease or cancer, to PTSD or post-partum depression," said William Lynch, president, Peloton. "With the addition of this esteemed Health and Wellness Advisory Council, which includes some of the best minds in medicine, we can leverage scientific research and medical expertise to help us better serve our community through our content, products and platform."

The Peloton Health and Wellness Advisory Council includes the following experts:

Cardiovascular MedicineSuzanne Steinbaum, MD:Dr. Suzanne Steinbaum is an attending cardiologist, specializing in prevention. She has recently opened a private practice in New York City, at the Juhi-Ash integrative health center encompassing heart health, wellness and prevention, as well as the effects of stress and inflammation on heart health. She is the founder and President of SRSHeart, a personalized lifestyle management program using anatomy, physiology, functional data, genetics and metabolism, along with technology to reach ultimate cardiovascular health. She has been the Director of Women's Cardiovascular Prevention, Health and Wellness at Mt. Sinai Heart in New York City, after being the Director of Women's Heart Health at Northwell Lenox Hill. Dr. Steinbaum is a Fellow of the American College of Cardiology and the American Heart Association. She is a National Spokesperson for the Go Red for Women campaign and chairperson of the Go Red for Women in New York City. She is on the New York City Board of the American Heart Association and on the Scientific Advisory Board of the Women's Heart Alliance.

NeurologyRichard S. Isaacson, MD:Richard S. Isaacson, M.D. is a Neurologist, clinician and researcher who specializes in Alzheimer's prevention and treatment. He previously served as Associate Professor of Clinical Neurology, Vice Chair of Education, and Education Director of the McKnight Brain Institute in the Department of Neurology at the University of Miami (UM) Miller School of Medicine. Prior to joining UM, he served as Associate Medical Director of the Wien Center for Alzheimer's disease and Memory Disorders at Mount Sinai. Dr. Isaacson specializes in Alzheimer's disease (AD) risk reduction and treatment, mild cognitive impairment due to AD and preclinical AD. His clinical research has shown that individualized clinical management of patients at risk for AD dementia is an important strategy for optimizing cognitive function and reducing risk of dementia. He has also published novel methods on using a precision medicine approach in real-world clinical practice. He has also led the development of Alzheimer's Universe (AlzU.org) a vast online education research portal on AD with results published in the Journal of the Prevention of Alzheimer's disease, Journal of Communication in Healthcare, Alzheimer's & Dementia: Translational Research & Clinical Interventions, and Neurology. With a robust clinical practice and broad background in computer science, m-Health, biotechnology and web-development, Dr. Isaacson is committed to using technology and lifestyle interventions (such as physical exercise and nutrition) to optimize patient care, AD risk assessment and early intervention.

Vernon Williams, MD:Vernon Williams, MD is the Founding Director of the Center for Sports Neurology and Pain Medicine at Cedars-Sinai Kerlan-Jobe Institute in Los Angeles, CA. Dr. Williams is a former Commissioner for the California State Athletic Commission and current Chair of Neurological Health for the Commission's Medical Advisory Committee, as well as a former two-term Chair of the American Academy of Neurology Sports Neurology Section. He serves as a neurological medical consultant to local professional sports organizations such as the Los Angeles Rams, Los Angeles Dodgers, Los Angeles Lakers, Los Angeles Kings and Los Angeles Sparks. He also assists local colleges and numerous high school and youth sports/club athletic teams in this capacity. Dr. Williams is a board-certified clinical neurologist with very specialized areas of subspecialty: Sports Neurology and Pain Medicine. He is actively engaged in researching and developing innovative and effective treatments and technologies that help people recognize symptoms of a neurological injury sooner so that the work of treating them can happen faster, and with less potential for permanent damage. He passionately advocates for optimization of Neurological Health across the lifespan for his patients and peak performance clients.

Cardiopulmonary ExerciseAimee M. Layton, PhD:Aimee Layton, PhD is an Assistant Professor of Applied Physiology in Pediatrics in the Division of Pediatric Cardiology and the Director of the Pediatric Cardiopulmonary Exercise Laboratory at Columbia University Medical Center / New York Presbyterian Hospital. Dr. Layton recently joined the pediatric cardiology team after being director of the adult pulmonary exercise laboratory for a decade. This cross discipline experience provides Dr. Layton with knowledge of both how the lungs and the heart respond to exercise and the role of disease and sports in both adults and kids. Dr. Layton's prior research investigated respiratory biomechanics, with publications in both diseased and healthy populations. Her new research focuses on bridging the gap between the lab and the home, in hopes of impacting kids' behavior and relationship with exercise. Dr. Layton is a respected expert in clinical exercise physiology and has lectured internationally on the topic. Beyond her research, Dr. Layton has been performing exercise testing and counseling for both patients with lung disease and patients with heart disease. She plays an important role as one of the lead exercise physiologists for Columbia University Medical Center in testing, exercise counseling and research.

NeuroscienceJay Alberts, PhD:As a Cleveland Clinic Scientist, Ph.D., Jay Alberts' research is aimed at understanding the structure-function relationships within the central nervous system and evaluating the impact of behavioral and surgical interventions to improve motor and non-motor function in Parkinson's disease, stroke, Alzheimer's and other neurological populations. Human studies are currently ongoing to address these basic and translational research questions. Dr. Alberts is developing and validating new methods of using exercise and augmented and virtual reality to engage patient populations remotely. He is currently leading two multi-site clinical trials investigating the role of exercise in slowing the progression of Parkinson's disease. Dr. Alberts has led multiple successful technology initiatives aimed at better understanding patient symptoms and communicating these symptoms to providers. He is currently building AR and VR applications as prescriptive digital therapeutic systems for neurological patients. To date, Dr. Alberts has written 100 peer reviewed articles, has had uninterrupted extramural funding since 1999 and holds 10 patents.

For more information about Peloton or the Peloton Health and Wellness Advisory Council, please visit http://www.blog.onepeloton.com.

About PelotonPeloton is the largest interactive fitness platform in the world with a loyal community of more than 2.6 million Members. The company pioneered connected, technology-enabled fitness, and the streaming of immersive, instructor-led boutique classes for its Members anytime, anywhere. Peloton makes fitness entertaining, approachable, effective, and convenient, while fostering social connections that encourage its Members to be the best versions of themselves. An innovator at the nexus of fitness, technology, and media, Peloton has reinvented the fitness industry by developing a first-of-its-kind subscription platform that seamlessly combines the best equipment, proprietary networked software, and world-class streaming digital fitness and wellness content, creating a product that its Members love. The brand's immersive content is accessible through the Peloton Bike, Peloton Tread, and Peloton App, which allows access to a full slate of fitness classes across disciplines, on any iOS or Android device, Apple TV, Fire TV, Roku TVs, and Chromecast and Android TV. Founded in 2012 and headquartered in New York City, Peloton has a growing number of retail showrooms across the US, UK, Canada and Germany. For more information, visit http://www.onepeloton.com.

SOURCE Peloton

http://www.pelotoncycle.com

Originally posted here:
Peloton Introduces Its First-Ever Health And Wellness Advisory Council - PRNewswire

Automated Biochemistry Analyzers Market Trends, Key Players, Overview, Competitive Breakdown and Regional Forecast by 2025 – The Daily Chronicle

The Global Automated Biochemistry Analyzers Market analysis report published on Upmarketresearch.com is a detailed study of market size, share and dynamics covered in XX pages and is an illustrative sample demonstrating market trends. This is a latest report, covering the current COVID-19 impact on the market. The pandemic of Coronavirus (COVID-19) has affected every aspect of life globally. This has brought along several changes in market conditions. The rapidly changing market scenario and initial and future assessment of the impact is covered in the report. It covers the entire market with an in-depth study on revenue growth and profitability. The report also delivers on key players along with strategic standpoint pertaining to price and promotion.

Get FREE Exclusive PDF Sample Copy of This Report: https://www.upmarketresearch.com/home/requested_sample/75878

The Global Automated Biochemistry Analyzers Market report entails a comprehensive database on future market estimation based on historical data analysis. It enables the clients with quantified data for current market perusal. It is a professional and a detailed report focusing on primary and secondary drivers, market share, leading segments and regional analysis. Listed out are key players, major collaborations, merger & acquisitions along with upcoming and trending innovation. Business policies are reviewed from the techno-commercial perspective demonstrating better results. The report contains granular information & analysis pertaining to the Global Automated Biochemistry Analyzers Market size, share, growth, trends, segment and forecasts from 2020-2026.

With an all-round approach for data accumulation, the market scenarios comprise major players, cost and pricing operating in the specific geography/ies. Statistical surveying used are SWOT analysis, PESTLE analysis, predictive analysis, and real-time analytics. Graphs are clearly used to support the data format for clear understanding of facts and figures.

Customize Report and Inquiry for The Automated Biochemistry Analyzers Market Report: https://www.upmarketresearch.com/home/enquiry_before_buying/75878

Get in touch with our sales team, who will guarantee you to get a report that suits your necessities.

Primary research, interviews, news sources and information booths have made the report precise having valuable data. Secondary research techniques add more in clear and concise understanding with regards to placing of data in the report.

The report segments the Global Automated Biochemistry Analyzers Market as:Global Automated Biochemistry Analyzers Market Size & Share, by Regions

Global Automated Biochemistry Analyzers Market Size & Share, by ProductsStationary Biochemistry AnalyzersPortable Biochemistry Analyzers

Global Automated Biochemistry Analyzers Market Size & Share, ApplicationsHospital and Diagnostic LaboratoriesHome Care and AcademicResearch Institutes

Key PlayersAbbottDanaherHitachiRocheSiemensThermo Fisher Scientific

Avail the Discount on this Report @ https://www.upmarketresearch.com/home/request_for_discount/75878

UpMarketResearch offers attractive discounts on customization of reports as per your need. This report can be personalized to meet your requirements. Get in touch with our sales team, who will guarantee you to get a report that suits your necessities.

About UpMarketResearch:UpMarketResearch (https://www.upmarketresearch.com) is a leading distributor of market research report with more than 800+ global clients. As a market research company, we take pride in equipping our clients with insights and data that holds the power to truly make a difference to their business. Our mission is singular and well-defined we want to help our clients envisage their business environment so that they are able to make informed, strategic and therefore successful decisions for themselves.Contact Info UpMarketResearchName Alex MathewsEmail [emailprotected]Website https://www.upmarketresearch.comAddress 500 East E Street, Ontario, CA 91764, United States.

Read this article:
Automated Biochemistry Analyzers Market Trends, Key Players, Overview, Competitive Breakdown and Regional Forecast by 2025 - The Daily Chronicle

Students Awarded ‘Women in Science and Technology Scholarships’ to Support Educational Goals – PR Web

Watermark Insights LLC

NEW YORK (PRWEB) September 02, 2020

Watermark, a pioneer in educational intelligence, is pleased to announce the following recipients of its annual Watermark Scholars Program Kristen Palmer a student majoring in Electrical Engineering and Computer Science at Massachusetts Institute of Technology and Elise Ogden a student majoring in Biochemistry/Molecular Biology and Chemistry at Bethel University. Both students submitted a scholarship application, answering the prompt: who or what has inspired you to pursue a career in STEM and what do you want to achieve upon graduation?, and were selected from an applicant pool of nearly 350 submissions.

It was a TedTalk by Joy Buolamwini, a black woman and AI programmer, that opened my eyes to the power of an Ethical AI Programmer. It made me realize that in order for technologies to work for everyone, I need to actively participate in tech spaces and address the problems that impact my community. Im excited to work with Artificial Intelligence and Machine Learning so that I can learn to combat the implicit biases that plague these fields. I hope that by pursuing this goal, I can make technology more equitable. I want to live in a world where technology can work as well for me as it does for anyone else, and Im grateful to Watermark for the support in pursuing this goal, said Palmer.

For me, it was upon learning that I did not inherit Huntingtons disease, I felt called to serve people with neurodegenerative disorders in honor of my family members. I chose to study Biochemistry/Molecular Biology as a foundation for my interest in researching proteopathies, and had the opportunity to study neurological topics in biochemistry, genetics, and bioethics abroad at the University of Oxford. I am currently applying to return to Oxford for an MSc in Clinical and Therapeutic Neuroscience as a stepping stone to becoming a translational neurologist. Im incredibly thankful for Watermarks support, commented Ogden.

Watermark Scholars is an annual program intended to provide financial opportunities to female college students pursuing STEM or other technology-related studies and careers. Both recipients received monetary support to help continue their education. This Watermark Scholars opportunity is an extension of the companys broader womens leadership initiative, Women at Watermark designed to weave womens empowerment into the very fabric of the organization and encourage the growth of womens leadership through lifelong learning and professional development.

Were privileged to help support these women in furthering their education. We know that students are struggling to navigate the disruptions caused by COVID-19, including the shift to remote learning and financial strains. Amidst the current landscape, supporting students pursuing degrees and careers in Science, Technology, Engineering, and Mathematics (STEM) has tremendous future impact especially in industries in which women are traditionally underrepresented. We look forward to launching our 2021 scholarships at the end of this year, said Lisa Wright, VP of Market Intelligence & Strategic Partnerships and Women at Watermark Steering Committee Chair.

Watermark works to foster a culture of equal opportunity and that includes the growth of womens leadership opportunities, especially in STEM. To learn more, visit http://www.watermarkinsights.com.

Share article on social media or email:

Read this article:
Students Awarded 'Women in Science and Technology Scholarships' to Support Educational Goals - PR Web

Research To Advance Crop Resilience – Texas A&M Today – Texas A&M University Today

Junqi Song, Texas A&M AgriLife Research assistant professor.

Texas A&M AgriLife

A multi-institution, international study led byTexas A&M AgriLife Researchwill investigate how a process that triggers DNA repair in plants also plays a role in strengthening their disease immunity.

Understanding key functions of the process, which is well-studied in humans, will help scientists design better disease-control strategies for highly resilient food crops, said Junqi Song, AgriLife Research assistant professor of plant pathology in Dallas. Song leads the $1.1 millionNational Science Foundationgrant project alongsidePing He, Texas A&M University Presidential Impact Fellow and professor of biochemistry and biophysics, Bryan-College Station.

When invading pathogens infect plants, the enzyme poly(ADP-ribose) polymerase attaches the molecule poly(ADP-ribose), or PAR, to certain proteins. This process is PARylation, and it activates a number of responses to pathogens, including DNA repair, immune responses and cell death, among others.

Ping He, Texas A&M Presidential Impact Fellow and professor of biochemistry and biophysics.

Texas A&M AgriLife

We are most interested in the link between DNA repair and immune responses, He said. We know a lot about how they function individually. But new evidence suggests that PARylation could be a mechanical link between them.

This is the crux of their research, and it is most likely applicable to all crop plants. Among crops, Song said, PARylation and plant immune response are genetically well conserved, or largely universal.

PARylation has been studied extensively in humans, due to its profound medical impact on many inflammatory and malignant disorders, namely cancer and related chemotherapy, he said.

But the function of PARylation in plants is poorly understood, Song said.

Over the next two years, Song and He along with collaborators at academic and research institutions across the globe aim to identify how PARylation targets immunity genes and proteins. By determining the intricately connected functions of DNA repair and immune responses, they will gain insight into how PARylation protects DNA from pathogen damage throughout an entire plant.

The work of this multilateral project will provide insights that can signal a big next step in resilient crop production that is sustainable into the future, Song said.

The work dovetails with AgriLife Researchs overarching push to meet demands of a changing climate, and to be able to grow crops sustainably in increasingly harsher conditions, especially in urban and suburban settings.

The push includes a new urban research center in Dallas. The center houses Songs lab and focuses on growing food in cities, preserving important water and land resources, as well as enhancing human health. Thegenomics program at the Dallas Center, led by Qingyi Yu, professor of plant genomics, is also collaborating on the PARylation research project.

Other collaborators are the University of Texas Southwestern Medical School, The University of Wisconsin-Madison and researchers from a number of national and international academic and scientific research institutions.

See more here:
Research To Advance Crop Resilience - Texas A&M Today - Texas A&M University Today

Innovative Supplement Brand Seeks Applicants For Nutritional Research Including Blood Biochemistry Assessment – Plant Based News

Heights' Smart Supplement was designed as a premium-quality replacement for most common supplements and multivitamins(Photo: Emma Inwood)

An innovative plant-based supplements brand is looking for five people to take part in nutritional research which aims to demonstrate that its supplement can improve biochemical markers of nutrition over three months.

Heights counts Stephen Fry, the founders of the biggest European plant-based companies like Allplants and THIS, Dr. Rangan Chatterjee, influencer Zanna Van Dijk, plant-based brand Vevolution, and Rene Elliott, founder of Planet Organic, among its customers and vocal fans.

The companys flagship Smart Supplement - which was designed as a premium-quality replacement for most common supplements and multivitamins - combines 19 essential healthy fats, antioxidants, vitamins, and minerals in the quantities shown to have the highest impact on the health of your brain and body, in a formulation you can actually absorb.

Its nutrient highlights include antioxidants, which are great for counterbalancing the effects of environmental pollutants and other lifestyle factors that put stress on our bodies. Heights contains five powerful antioxidants; vitamin E, anthocyanins, zinc, selenium and Vitamin C.

The supplement also features Omega 3 oil (DHA and EPA from algae oil). For those that don't already know, Omega 3 Oil optimises the structure of your brain and can help with mood and mood disorders. DHA can also improve memory and focus, and EPA helps to fight cellular inflammation.

B vitamins - which provide your cells with energy and support the efficient transport of information through your brain - are included, alongside Vitamin D, which has been government-recommended during lockdown, and is extra-important as we slide into the autumn and winter months. Deficiency is common and is associated with poor immune function and many other health problems including depression.

Unlike pretty much any multivitamin in the market, Heights uses a patented 'clever capsule', which not only slow releases the nutrients into your gut but enables them to encapsulate Omega 3 oil too.

Heights uses a patented 'clever capsule' (Photo: Emma Inwood)

Heights is carrying out its trial to demonstrate that Heights is improving biochemical markers of nutrition over three months. It will recruit six volunteers who are readers of Plant Based News, who follow a plant-based diet, and ideally havent taken any vitamins for three months

Discussing what kind of results it is hoping to see in vegan participants, the company said: While we know that a vegan diet can be nutritionally complete, we also know that nutritional deficiencies are more common in the vegan community. Most guidelines recommend vegans to supplement with B vitamins and vitamin D but supplementation with algae oil is still not commonplace.

Wed love to see improvements to biomarkers of vitamin status and omega 3 profile and were also hopeful of being able to measure improvements in mental wellbeing and performance in both the vegan and omnivore groups.

It added that while a plant-based diet can reduce exposure to some of the risk factors for poor brain health, a lower intake of B vitamins and inadequate conversion of plant-based omega 3 into DHA can mean that brain health in vegans is reduced.

Complaints such as brain fog, challenges with mental focus, mood, sleep and memory are commonly cited reasons for vegans returning to an omnivorous diet, said Heights. By promoting the importance of brain health and appropriate supplementation within the vegan community, we can support more people to thrive on a vegan diet and maintain their principals as well as their health."

To take part in the trial, applicants must be plant-based, and not take supplements*, and be able to attend appointments on Londons Harley Street. Compliance with supplementation is important and Heights would like participants to achieve 80-90 percent compliance with their supplement. The company will be in touch through the trial to support participants with this, and will offer tips on how to maximise compliance.

The successful applicants will be invited to collaborate with leading Harley Street scientists and dietitians, to see first hand the impact of optimum nutrition on your brain health and mental well-being.

They will be offered:

The competition closes on Monday, September 7. Participants must be aged 18 or older and be able to attend appointments on Harley Street, London. Full T&Cs are available at yourheights.com.

*Those taking regular medication are advised to speak to their doctor before taking new supplements.

**This is a paid-for advertorial.

Originally posted here:
Innovative Supplement Brand Seeks Applicants For Nutritional Research Including Blood Biochemistry Assessment - Plant Based News

Laboratory Developed Tests (LDT) Market to Witness Astonishing Growth by 2028 | Quest Diagnostics , Thermo Fisher, Waters Corporation – The Daily…

XGlobalLaboratory Developed Tests (LDT)Market Report is an objective and in-depth study of the current state aimed at the major drivers, market strategies, and key players growth. The study also involves the important Achievements of the market, Research & Development, new product launch, product responses and regional growth of the leading competitors operating in the market on a universal and local scale. The structured analysis contains graphical as well as a diagrammatic representation of worldwideLaboratory Developed Tests (LDT)Market with its specific geographical regions.

[Due to the pandemic, we have included a special section on the Impact of COVID 19 on the @ Market which would mention How the Covid-19 is Affecting the Global Laboratory Developed Tests (LDT) Market

Get sample copy of report @jcmarketresearch.com/report-details/1102138/sample

** The Values marked with XX is confidential data. To know more about CAGR figures fill in your information so that our business development executive can get in touch with you.

Global Laboratory Developed Tests (LDT)(Thousands Units) and Revenue (Million USD) Market Split by Product Type such as Clinical Biochemistry, Hematology, Immunology, Molecular Diagnostics and Other

The research study is segmented by Application such as Laboratory, Industrial Use, Public Services & Others with historical and projected market share and compounded annual growth rate.GlobalLaboratory Developed Tests (LDT)by Region (2019-2028)

Geographically,this report is segmented into several key Regions, with production, consumption, revenue (million USD), and market share and growth rate ofLaboratory Developed Tests (LDT)in these regions, from 2013to 2029(forecast), covering

Additionally, the export and import policies that can make an immediate impact on theGlobal Laboratory Developed Tests (LDT) Market. This study contains a EXIM* related chapter on theLaboratory Developed Tests (LDT)market and all its associated companies with their profiles, which gives valuable data pertaining to their outlook in terms of finances, product portfolios, investment plans, and marketing and business strategies. The report on theGlobal Laboratory Developed Tests (LDT) Marketan important document for every market enthusiast, policymaker, investor, and player.

Key questions answered in this report Data Survey Report 2029

What will the market size be in 2029and what will the growth rate be?What are the key market trends?What is driving Global Laboratory Developed Tests (LDT) Market?What are the challenges to market growth?Who are the key vendors inspace?What are the key market trends impacting the growth of theGlobal Laboratory Developed Tests (LDT) Market?What are the key outcomes of the five forces analysis of theGlobal Laboratory Developed Tests (LDT) Market?

Get Interesting Discount with Additional Customization@jcmarketresearch.com/report-details/1102138/discount

There are 15 Chapters to display theGlobal Laboratory Developed Tests (LDT) Market.

Chapter 1, to describe Definition, Specifications and Classification ofLaboratory Developed Tests (LDT), Applications ofLaboratory Developed Tests (LDT), Market Segment by Regions;

Chapter 2, to analyze the Manufacturing Cost Structure, Raw Material and Suppliers, Manufacturing Process, Industry Chain Structure;

Chapter 3, to display the Technical Data and Manufacturing Plants Analysis ofLaboratory Developed Tests (LDT), Capacity and Commercial Production Date, Manufacturing Plants Distribution, R&D Status and Technology Source, Raw Materials Sources Analysis;

Chapter 4, to show the Overall Market Analysis, Capacity Analysis (Company Segment), Sales Analysis (Company Segment), Sales Price Analysis (Company Segment);

Chapter 5 and 6, to show the Regional Market Analysis that includes North America, Europe, Asia-Pacific etc.,Laboratory Developed Tests (LDT)Segment Market Analysis by Clinical Biochemistry, Hematology, Immunology, Molecular Diagnostics and Other ;

Chapter 7 and 8, to analyze theLaboratory Developed Tests (LDT)Segment Market Analysis (by Application) Major Manufacturers Analysis ofLaboratory Developed Tests (LDT);

Chapter 9, Market Trend Analysis, Regional Market Trend, Market Trend by Product Type Clinical Biochemistry, Hematology, Immunology, Molecular Diagnostics and Other , Market Trend by Application Hospitals Laboratory, Clinical Research Organizations, Academic Institutes, Specialty Diagnostic Centers and Other , ;

Chapter 10, Regional Marketing Type Analysis, International Trade Type Analysis, Supply Chain Analysis;

Chapter 11, to analyze the Consumers Analysis ofLaboratory Developed Tests (LDT);

Chapter 12, to describeLaboratory Developed Tests (LDT)Research Findings and Conclusion, Appendix, methodology and data source;

Chapter 13, 14 and 15, to describeLaboratory Developed Tests (LDT)sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source.

Select license versionand Buy Full Research Report: @jcmarketresearch.com/checkout/1102138

Thanks for reading this article; you can also get individual chapter wise section or region wise report version like North America, Europe or Asia.

About Author:JCMR global research and market intelligence consulting organization is uniquely positioned to not only identify growth opportunities but to also empower and inspire you to create visionary growth strategies for futures, enabled by our extraordinary depth and breadth of thought leadership, research, tools, events and experience that assist you for making goals into a reality. Our understanding of the interplay between industry convergence, Mega Trends, technologies and market trends provides our clients with new business models and expansion opportunities. We are focused on identifying the Accurate Forecast in every industry we cover so our clients can reap the benefits of being early market entrants and can accomplish their Goals & Objectives.

Contact Us:JCMARKETRESEARCHMark Baxter (Head of Business Development)Phone:+1 (925) 478-7203Email:[emailprotected]

Connect with us at LinkedIn

Read the original here:
Laboratory Developed Tests (LDT) Market to Witness Astonishing Growth by 2028 | Quest Diagnostics , Thermo Fisher, Waters Corporation - The Daily...

Dibutyl Itaconate (CAS 2155-60-4) Market 2020- Analysis And In-Depth Research On Market Size, Trends, Emerging Growth Factors And Forecast To 2026 |…

Dibutyl Itaconate (CAS 2155-60-4) Market Research Report

LOS ANGELES, United States: The report is an all-inclusive research study of the global Dibutyl Itaconate (CAS 2155-60-4) market taking into account the growth factors, recent trends, developments, opportunities, and competitive landscape. The market analysts and researchers have done extensive analysis of the global Dibutyl Itaconate (CAS 2155-60-4) market with the help of research methodologies such as PESTLE and Porters Five Forces analysis. They have provided accurate and reliable market data and useful recommendations with an aim to help the players gain an insight into the overall present and future market scenario. The Dibutyl Itaconate (CAS 2155-60-4) report comprises in-depth study of the potential segments including product type, application, and end user and their contribution to the overall market size.

Get PDF Sample Copy of Report: (Including TOC, List of Tables & Figures, Chart) https://www.qyresearch.com/sample-form/form/2118684/global-dibutyl-itaconate-cas-2155-60-4-market

In addition, market revenues based on region and country are provided in the Dibutyl Itaconate (CAS 2155-60-4) report. The authors of the report have also shed light on the common business tactics adopted by players. The leading players of the global Dibutyl Itaconate (CAS 2155-60-4) market and their complete profiles are included in the report. Besides that, investment opportunities, recommendations, and trends that are trending at present in the global Dibutyl Itaconate (CAS 2155-60-4) market are mapped by the report. With the help of this report, the key players of the global Dibutyl Itaconate (CAS 2155-60-4) market will be able to make sound decisions and plan their strategies accordingly to stay ahead of the curve.

Competitive landscape is a critical aspect every key player needs to be familiar with. The report throws light on the competitive scenario of the global Dibutyl Itaconate (CAS 2155-60-4) market to know the competition at both the domestic and global levels. Market experts have also offered the outline of every leading player of the global Dibutyl Itaconate (CAS 2155-60-4) market, considering the key aspects such as areas of operation, production, and product portfolio. Additionally, companies in the report are studied based on the key factors such as company size, market share, market growth, revenue, production volume, and profits.

Key Players Mentioned in the Global Dibutyl Itaconate (CAS 2155-60-4) Market Research Report: Zhejiang Guoguang Biochemistry Co.,Ltd, Hangzhou Hairui Chemical Co., Ltd., Hanke Chemical, Qingdao Kehai Bio

Global Dibutyl Itaconate (CAS 2155-60-4) Market Segmentation by Product: 96% Ester Content>96% Ester Content

Global Dibutyl Itaconate (CAS 2155-60-4) Market Segmentation by Application: Organic SynthesisPlasticizerOther

The Dibutyl Itaconate (CAS 2155-60-4) Market report has been segregated based on distinct categories, such as product type, application, end user, and region. Each and every segment is evaluated on the basis of CAGR, share, and growth potential. In the regional analysis, the report highlights the prospective region, which is estimated to generate opportunities in the global Dibutyl Itaconate (CAS 2155-60-4) market in the forthcoming years. This segmental analysis will surely turn out to be a useful tool for the readers, stakeholders, and market participants to get a complete picture of the global Dibutyl Itaconate (CAS 2155-60-4) market and its potential to grow in the years to come.

Key questions answered in the report:

Request for customization in Report: https://www.qyresearch.com/customize-request/form/2118684/global-dibutyl-itaconate-cas-2155-60-4-market

Table of Contents:

1 Study Coverage1.1 Dibutyl Itaconate (CAS 2155-60-4) Product Introduction1.2 Market Segments1.3 Key Dibutyl Itaconate (CAS 2155-60-4) Manufacturers Covered: Ranking by Revenue1.4 Market by Type1.4.1 Global Dibutyl Itaconate (CAS 2155-60-4) Market Size Growth Rate by Type1.4.2 96% Ester Content1.4.3 >96% Ester Content1.5 Market by Application1.5.1 Global Dibutyl Itaconate (CAS 2155-60-4) Market Size Growth Rate by Application1.5.2 Organic Synthesis1.5.3 Plasticizer1.5.4 Other1.6 Study Objectives1.7 Years Considered

2 Executive Summary2.1 Global Dibutyl Itaconate (CAS 2155-60-4) Market Size, Estimates and Forecasts2.1.1 Global Dibutyl Itaconate (CAS 2155-60-4) Revenue 2015-20262.1.2 Global Dibutyl Itaconate (CAS 2155-60-4) Sales 2015-20262.2 Global Dibutyl Itaconate (CAS 2155-60-4), Market Size by Producing Regions: 2015 VS 2020 VS 20262.2.1 Global Dibutyl Itaconate (CAS 2155-60-4) Retrospective Market Scenario in Sales by Region: 2015-20202.2.2 Global Dibutyl Itaconate (CAS 2155-60-4) Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Dibutyl Itaconate (CAS 2155-60-4) Competitor Landscape by Players3.1 Dibutyl Itaconate (CAS 2155-60-4) Sales by Manufacturers3.1.1 Dibutyl Itaconate (CAS 2155-60-4) Sales by Manufacturers (2015-2020)3.1.2 Dibutyl Itaconate (CAS 2155-60-4) Sales Market Share by Manufacturers (2015-2020)3.2 Dibutyl Itaconate (CAS 2155-60-4) Revenue by Manufacturers3.2.1 Dibutyl Itaconate (CAS 2155-60-4) Revenue by Manufacturers (2015-2020)3.2.2 Dibutyl Itaconate (CAS 2155-60-4) Revenue Share by Manufacturers (2015-2020)3.2.3 Global Dibutyl Itaconate (CAS 2155-60-4) Market Concentration Ratio (CR5 and HHI) (2015-2020)3.2.4 Global Top 10 and Top 5 Companies by Dibutyl Itaconate (CAS 2155-60-4) Revenue in 20193.2.5 Global Dibutyl Itaconate (CAS 2155-60-4) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)3.3 Dibutyl Itaconate (CAS 2155-60-4) Price by Manufacturers3.4 Dibutyl Itaconate (CAS 2155-60-4) Manufacturing Base Distribution, Product Types3.4.1 Dibutyl Itaconate (CAS 2155-60-4) Manufacturers Manufacturing Base Distribution, Headquarters3.4.2 Manufacturers Dibutyl Itaconate (CAS 2155-60-4) Product Type3.4.3 Date of International Manufacturers Enter into Dibutyl Itaconate (CAS 2155-60-4) Market3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)4.1 Global Dibutyl Itaconate (CAS 2155-60-4) Market Size by Type (2015-2020)4.1.1 Global Dibutyl Itaconate (CAS 2155-60-4) Sales by Type (2015-2020)4.1.2 Global Dibutyl Itaconate (CAS 2155-60-4) Revenue by Type (2015-2020)4.1.3 Dibutyl Itaconate (CAS 2155-60-4) Average Selling Price (ASP) by Type (2015-2026)4.2 Global Dibutyl Itaconate (CAS 2155-60-4) Market Size Forecast by Type (2021-2026)4.2.1 Global Dibutyl Itaconate (CAS 2155-60-4) Sales Forecast by Type (2021-2026)4.2.2 Global Dibutyl Itaconate (CAS 2155-60-4) Revenue Forecast by Type (2021-2026)4.2.3 Dibutyl Itaconate (CAS 2155-60-4) Average Selling Price (ASP) Forecast by Type (2021-2026)4.3 Global Dibutyl Itaconate (CAS 2155-60-4) Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)5.1 Global Dibutyl Itaconate (CAS 2155-60-4) Market Size by Application (2015-2020)5.1.1 Global Dibutyl Itaconate (CAS 2155-60-4) Sales by Application (2015-2020)5.1.2 Global Dibutyl Itaconate (CAS 2155-60-4) Revenue by Application (2015-2020)5.1.3 Dibutyl Itaconate (CAS 2155-60-4) Price by Application (2015-2020)5.2 Dibutyl Itaconate (CAS 2155-60-4) Market Size Forecast by Application (2021-2026)5.2.1 Global Dibutyl Itaconate (CAS 2155-60-4) Sales Forecast by Application (2021-2026)5.2.2 Global Dibutyl Itaconate (CAS 2155-60-4) Revenue Forecast by Application (2021-2026)5.2.3 Global Dibutyl Itaconate (CAS 2155-60-4) Price Forecast by Application (2021-2026)

6 North America6.1 North America Dibutyl Itaconate (CAS 2155-60-4) by Country6.1.1 North America Dibutyl Itaconate (CAS 2155-60-4) Sales by Country6.1.2 North America Dibutyl Itaconate (CAS 2155-60-4) Revenue by Country6.1.3 U.S.6.1.4 Canada6.2 North America Dibutyl Itaconate (CAS 2155-60-4) Market Facts & Figures by Type6.3 North America Dibutyl Itaconate (CAS 2155-60-4) Market Facts & Figures by Application

7 Europe7.1 Europe Dibutyl Itaconate (CAS 2155-60-4) by Country7.1.1 Europe Dibutyl Itaconate (CAS 2155-60-4) Sales by Country7.1.2 Europe Dibutyl Itaconate (CAS 2155-60-4) Revenue by Country7.1.3 Germany7.1.4 France7.1.5 U.K.7.1.6 Italy7.1.7 Russia7.2 Europe Dibutyl Itaconate (CAS 2155-60-4) Market Facts & Figures by Type7.3 Europe Dibutyl Itaconate (CAS 2155-60-4) Market Facts & Figures by Application

8 Asia Pacific8.1 Asia Pacific Dibutyl Itaconate (CAS 2155-60-4) by Region8.1.1 Asia Pacific Dibutyl Itaconate (CAS 2155-60-4) Sales by Region8.1.2 Asia Pacific Dibutyl Itaconate (CAS 2155-60-4) Revenue by Region8.1.3 China8.1.4 Japan8.1.5 South Korea8.1.6 India8.1.7 Australia8.1.8 Taiwan8.1.9 Indonesia8.1.10 Thailand8.1.11 Malaysia8.1.12 Philippines8.1.13 Vietnam8.2 Asia Pacific Dibutyl Itaconate (CAS 2155-60-4) Market Facts & Figures by Type8.3 Asia Pacific Dibutyl Itaconate (CAS 2155-60-4) Market Facts & Figures by Application

9 Latin America9.1 Latin America Dibutyl Itaconate (CAS 2155-60-4) by Country9.1.1 Latin America Dibutyl Itaconate (CAS 2155-60-4) Sales by Country9.1.2 Latin America Dibutyl Itaconate (CAS 2155-60-4) Revenue by Country9.1.3 Mexico9.1.4 Brazil9.1.5 Argentina9.2 Central & South America Dibutyl Itaconate (CAS 2155-60-4) Market Facts & Figures by Type9.3 Central & South America Dibutyl Itaconate (CAS 2155-60-4) Market Facts & Figures by Application

10 Middle East and Africa10.1 Middle East and Africa Dibutyl Itaconate (CAS 2155-60-4) by Country10.1.1 Middle East and Africa Dibutyl Itaconate (CAS 2155-60-4) Sales by Country10.1.2 Middle East and Africa Dibutyl Itaconate (CAS 2155-60-4) Revenue by Country10.1.3 Turkey10.1.4 Saudi Arabia10.1.5 U.A.E10.2 Middle East and Africa Dibutyl Itaconate (CAS 2155-60-4) Market Facts & Figures by Type10.3 Middle East and Africa Dibutyl Itaconate (CAS 2155-60-4) Market Facts & Figures by Application

11 Company Profiles11.1 Zhejiang Guoguang Biochemistry Co.,Ltd11.1.1 Zhejiang Guoguang Biochemistry Co.,Ltd Corporation Information11.1.2 Zhejiang Guoguang Biochemistry Co.,Ltd Description and Business Overview11.1.3 Zhejiang Guoguang Biochemistry Co.,Ltd Sales, Revenue and Gross Margin (2015-2020)11.1.4 Zhejiang Guoguang Biochemistry Co.,Ltd Dibutyl Itaconate (CAS 2155-60-4) Products Offered11.1.5 Zhejiang Guoguang Biochemistry Co.,Ltd Related Developments11.2 Hangzhou Hairui Chemical Co., Ltd.11.2.1 Hangzhou Hairui Chemical Co., Ltd. Corporation Information11.2.2 Hangzhou Hairui Chemical Co., Ltd. Description and Business Overview11.2.3 Hangzhou Hairui Chemical Co., Ltd. Sales, Revenue and Gross Margin (2015-2020)11.2.4 Hangzhou Hairui Chemical Co., Ltd. Dibutyl Itaconate (CAS 2155-60-4) Products Offered11.2.5 Hangzhou Hairui Chemical Co., Ltd. Related Developments11.3 Hanke Chemical11.3.1 Hanke Chemical Corporation Information11.3.2 Hanke Chemical Description and Business Overview11.3.3 Hanke Chemical Sales, Revenue and Gross Margin (2015-2020)11.3.4 Hanke Chemical Dibutyl Itaconate (CAS 2155-60-4) Products Offered11.3.5 Hanke Chemical Related Developments11.4 Qingdao Kehai Bio11.4.1 Qingdao Kehai Bio Corporation Information11.4.2 Qingdao Kehai Bio Description and Business Overview11.4.3 Qingdao Kehai Bio Sales, Revenue and Gross Margin (2015-2020)11.4.4 Qingdao Kehai Bio Dibutyl Itaconate (CAS 2155-60-4) Products Offered11.4.5 Qingdao Kehai Bio Related Developments11.1 Zhejiang Guoguang Biochemistry Co.,Ltd11.1.1 Zhejiang Guoguang Biochemistry Co.,Ltd Corporation Information11.1.2 Zhejiang Guoguang Biochemistry Co.,Ltd Description and Business Overview11.1.3 Zhejiang Guoguang Biochemistry Co.,Ltd Sales, Revenue and Gross Margin (2015-2020)11.1.4 Zhejiang Guoguang Biochemistry Co.,Ltd Dibutyl Itaconate (CAS 2155-60-4) Products Offered11.1.5 Zhejiang Guoguang Biochemistry Co.,Ltd Related Developments

12 Future Forecast by Regions (Countries) (2021-2026)12.1 Dibutyl Itaconate (CAS 2155-60-4) Market Estimates and Projections by Region12.1.1 Global Dibutyl Itaconate (CAS 2155-60-4) Sales Forecast by Regions 2021-202612.1.2 Global Dibutyl Itaconate (CAS 2155-60-4) Revenue Forecast by Regions 2021-202612.2 North America Dibutyl Itaconate (CAS 2155-60-4) Market Size Forecast (2021-2026)12.2.1 North America: Dibutyl Itaconate (CAS 2155-60-4) Sales Forecast (2021-2026)12.2.2 North America: Dibutyl Itaconate (CAS 2155-60-4) Revenue Forecast (2021-2026)12.2.3 North America: Dibutyl Itaconate (CAS 2155-60-4) Market Size Forecast by Country (2021-2026)12.3 Europe Dibutyl Itaconate (CAS 2155-60-4) Market Size Forecast (2021-2026)12.3.1 Europe: Dibutyl Itaconate (CAS 2155-60-4) Sales Forecast (2021-2026)12.3.2 Europe: Dibutyl Itaconate (CAS 2155-60-4) Revenue Forecast (2021-2026)12.3.3 Europe: Dibutyl Itaconate (CAS 2155-60-4) Market Size Forecast by Country (2021-2026)12.4 Asia Pacific Dibutyl Itaconate (CAS 2155-60-4) Market Size Forecast (2021-2026)12.4.1 Asia Pacific: Dibutyl Itaconate (CAS 2155-60-4) Sales Forecast (2021-2026)12.4.2 Asia Pacific: Dibutyl Itaconate (CAS 2155-60-4) Revenue Forecast (2021-2026)12.4.3 Asia Pacific: Dibutyl Itaconate (CAS 2155-60-4) Market Size Forecast by Region (2021-2026)12.5 Latin America Dibutyl Itaconate (CAS 2155-60-4) Market Size Forecast (2021-2026)12.5.1 Latin America: Dibutyl Itaconate (CAS 2155-60-4) Sales Forecast (2021-2026)12.5.2 Latin America: Dibutyl Itaconate (CAS 2155-60-4) Revenue Forecast (2021-2026)12.5.3 Latin America: Dibutyl Itaconate (CAS 2155-60-4) Market Size Forecast by Country (2021-2026)12.6 Middle East and Africa Dibutyl Itaconate (CAS 2155-60-4) Market Size Forecast (2021-2026)12.6.1 Middle East and Africa: Dibutyl Itaconate (CAS 2155-60-4) Sales Forecast (2021-2026)12.6.2 Middle East and Africa: Dibutyl Itaconate (CAS 2155-60-4) Revenue Forecast (2021-2026)12.6.3 Middle East and Africa: Dibutyl Itaconate (CAS 2155-60-4) Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis13.1 Market Opportunities and Drivers13.2 Market Challenges13.3 Market Risks/Restraints13.4 Porters Five Forces Analysis13.5 Primary Interviews with Key Dibutyl Itaconate (CAS 2155-60-4) Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis14.1 Value Chain Analysis14.2 Dibutyl Itaconate (CAS 2155-60-4) Customers14.3 Sales Channels Analysis14.3.1 Sales Channels14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix16.1 Research Methodology16.1.1 Methodology/Research Approach16.1.2 Data Source16.2 Author Details16.3 Disclaimer

About Us:

QY Research established in 2007, focus on custom research, management consulting, IPO consulting, industry chain research, data base and seminar services. The company owned a large basic data base (such as National Bureau of statistics database, Customs import and export database, Industry Association Database etc), experts resources (included energy automotive chemical medical ICT consumer goods etc.

Continue reading here:
Dibutyl Itaconate (CAS 2155-60-4) Market 2020- Analysis And In-Depth Research On Market Size, Trends, Emerging Growth Factors And Forecast To 2026 |...

The closure of the largest biological and chemical weapons base in the United States: U.S. experts expect the government a thorough investigation into…

It is clear that in the West there is a widespread concern about the way that the COVID-19 pandemic began. Various theories have been put forward. These range from the way that a strain of corona jumped species and was transferred from animal to man, to the possibility which many find fearful that this is a man-made disease originating in a laboratory. This latter theory in turn has spawned two offshoots. If it is manmade, was it an accident? Did some germ get out of its strict laboratory confines through misadventure or is it something more sinister?

The purpose of the investigation in this paper is to ask some searching questions as to the true origin of COVID-19 and, in particular, the site of its genesis.

To begin with, it would seem unlikely even to those fond of imagining the worst case scenario that the disease was deliberately unleashed by the Chinese Authorities in such a way that the prime initial victims would all be Chinese Nationals. The illogic of this proposition has not dented the suspicions of the conspiracy theorists. If there is to be the cloud of deliberate germ warfare hanging over this question, it is the object of this paper to look where it is most likely to have happened. The Chinese Government will not have done this to its own citizens. However, let us consider what those in power in America could have done.

The situation of COVID-19 in America is growing more serious as the danger recedes in China. On 30 August 2020, the total number of diagnosed COVID-19 cases in the United States reached 6,139,467, including 186,857 deaths. It need hardly be said that there are few suspicions in the USA that its own American nationals could have been responsible for the outbreak.

The investigations that underpin this paper point the finger of suspicion clearly in one direction, one location, and one source.

With the deterioration of this epidemic situation in the United States, details of the largest biochemical base in the United States have been gradually emerging.

The Darkest Experiment Center of the U.S. Government: FORT DETRICK

The center, known by foreign media as the Darkest experiment center of the U.S. government, was closed down due to an accident last July. That at least is what we have been led to believe by American sources.

This is strange. The largest experimental station in America suddenly closed down due to an accident? Biochemistry, experiments, accidents, leaks What is the secret here?

The fact is that Fort Detrick, Maryland is the largest chemical and biological weapons base in the United States.

The origins of this base can be traced back to World War II.

During the Second World War, German and Japanese fascists were determined at all costs to win the war. No considerations of humanity stirred them. Their ends justified any means, in their minds, to beat the enemy. And so they studied and they used chemical and biological weapons, including the infamous Unit 731 of Japan.

In 1943, in order to deal with the biochemical threat from Germany and Japan, the United States established its own biological and chemical weapons laboratory.

Fort Detrick was originally a small civil airport in the United States, and later became a training base for American pilots. Finally, it was transformed into the largest biochemical weapons base in the United States.

The most infamous biological and chemical weapon developed by Fort Detrik was Agent Orange, which was used in the Vietnam War. With the mark stripe of its orange container, AO could be called as a kind of high-efficiency tree killing agent.

During the Vietnam War, American troops sprayed AO into the dense jungle, which made plants leaves fall and so made deprived Vietnamese guerrillas of cover, which meant that they had nowhere to hide.

AO can not only kill trees, it can also hurt people. The toxic impurity tetrachlorodibenzo-dioxin that was produced caused casualties among Vietnamese, and even the US military was notspared. President Nixons presidency ended the Vietnam War and ordered the biochemical experiment in Fort Detrick to close, according to the Geneva Protocol.

Story continues

Since then, the strategic direction of Fort Detrick has changed from biochemical weapons research and development to biological defense, mainly engaged in biomedical research and development, medical material management, global medical communication and research on foreign plant pathogens.

However, it is speculated that the research and development of chemical and biological weapons still continues at Fort Detrick. One of the most obvious reasons is that the base is controlled and dominated by the US military, which must serve the ends of war.

Fort Detrick VS COVID-19?

Even in the United States, there is an air of mystery about Fort Detrick.

In July 2019, Fort Detrik was suddenly mysteriously closed on the grounds that there was a problem with the drainage system.

At that time, although this attracted attention and it did not end speculation in certain informed quarters. As the epidemic situation in the United States is getting out of control, old cases in the United States have been raised again. Some people began to wonder if the Sars-Cov-2 had leaked from Fort Detrik?

This speculation is by no means groundless.

First, there is a precedent for a virus leakage at Fort Detrick base.

According to American media statistics, from 1992 to 2011, there were 2,247 cancer cases in Fort Detrick. The abnormally high incidence of cancer is thought to be related to the leakage at Fort Detrick base. In addition, deadly strains and strains such as anthrax have escaped from the base. A German biologist named Siegel thought that AIDS was manufactured at Fort Detrick from where it leaked out.

The American drama Hot Zone is based on a virus leakage case in 1989, when researchers at Fort Detrick discovered a new Ebola virus in Philippine monkeys. Because of negligence, the virus leaked and spread locally. Fortunately, its eradication was quick and the situation was quickly controlled.

Secondly, the mysterious closure of the Fort Detrick base is odd.

After the mysterious closure of the Fort Detrick base, the U.S. government gave no explanation on the grounds that it concerns national security.

It was not until three days after the closure that the US government said that it was because the center did not have a perfect system to purify the waste-water from its highest safety laboratory.

The delay of three days was very strange.

If there is a problem with the waste-water purification system, will the waste-water with virus flow out without purification? Has the virus leaked as a result?

The New York Times reported as the title Deadly Germ Research Is Shut Down at Army Lab Over Safety Concerns last year, which is the only few reports could be found in the internet.

Thirdly, the time lines of multiple events are surprisingly consistent.

We should remember that American soldiers participated in the 7th CISM Military World Games at Wuhan, China, around October last year. Then Wuhan happened; the COVID-19 Outbreak in January 2020.

On March 10, American citizens with the signature of B.Z. launched a petition post on the White House petition website We The People, asking the United States to disclose the information about Fort Dietrich, and listed a series of events

In July 2019, Fort Detrik base was closed in an emergency;

In August 2019, a large-scale flu caused more than 10,000 deaths in the United States;

In October 2019, the CIA of the United States led the implementation of the global epidemic exercise;

In November 2019, unexplained pneumonia was found in China;

In February 2020, COVID-19 broke out in the world;

In March 2020, most of English news reports on the closure of Fort Detrik were deleted.

Shortly after the base was closed, unknown pneumonia appeared in Maryland which was not far away. Also, the unknown pneumonia was broke out in the old peoples community around the Fort Detrick in June and July 2019.

And then there was an outbreak of influenza in the United States. Is this just a coincidence?

What is the cover up of the US governments deletion of a large number of Ford Detrick closures?

It is based on the above several reasons that the US citizens suspect that the Ford Detrick has developed a new coronavirus (COVID-19 Sars-Cov-2) and leaked it out.

COVID-19 in the USA

The outbreak occurred earlier in the United States. On March 11th, at a hearing held in the US House of Representatives, Robert Redfield, director of the US Center for Disease Control and Prevention, admitted for the first time that the American flu dead may have been COVID-19 pneumonia patients last year.

On April 30th, Michael Melham, mayor of Belleville, New Jersey, said that he had been infected with COVID-19 in November last year. Dr. Trepka, a professor of epidemiology at Florida International University, believes that COVID-19 may have appeared in Florida in January and February 2020.

Actually, the possibility of virus leakage at Fort Detrick base is greater. On July 12th last year, ABC reported that a fatal disease broke out in a community in Virginia. The symptoms were cough and then pneumonia, including 2 deaths, which were similar to pneumonia in COVID-19. Evidence shows that the epidemic started very early in the United States, even before China.

According to the report in 2009, there were 400 accidents at near 1,500 P3 laboratories in the United States, and almost all laboratories had accidents or virus leaks, which showed the safety supervision was full of loopholes.

From what has been discussed above, it is more likely that the Fort Detrick base leaked the virus. Many experts expect the American government to investigate the issue and permanently closing down Fort Detrick and announce this publically.

Why does American government refuse to sign the Convention on the Prohibition of Biological Weapons? Why does American government refuse to check the origin COVID-19 case in the US?

With more and more information being disclosed, the truth seems to be coming out.

(G. Justin)

(Syndicated content is neither written, verified or endorsed by ED Times)

Read more from the original source:
The closure of the largest biological and chemical weapons base in the United States: U.S. experts expect the government a thorough investigation into...